Immune-related serious adverse events with immune checkpoint inhibitors: Systematic review and network meta-analysis

ConclusionEach ICI showed a unique safety profile, with certain events more frequently observed with specific ICIs, which should be considered when managing cancer patients.
Source: European Journal of Clinical Pharmacology - Category: Drugs & Pharmacology Source Type: research